Showing results (301-310 of 584) with videos related to
Sort By:
Pageof 59
Journal of Cardiovascular Pharmacology|November 15, 2000
Gender differences in hemodynamic responses to endothelin-1R Tatchum-Talom, C Martel, C Labrie, et al.Biochimica Et Biophysica Acta|March 1, 1996
Heterogeneity of rat type I 5 alpha-reductase cDNA: cloning, expression and regulation by pituitary implants and dihydrotestosteroneI Lopez-Solache, V Luu-The, G E Séralini, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 24, 2004
Cellular localization of mRNA expression of enzymes involved in the formation and inactivation of hormonal steroids in the mouse prostateG Pelletier, V Luu-The, S Li, et al.Molecular and Cellular Endocrinology|August 1, 1994
Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkeyC Martel, M H Melner, D Gagné, et al.Steroids|December 1, 1982
Comparative effects of LHRH agonist and ovine LH administration on testicular steroidogenesis in intact adult ratR Carmichael, A Belanger, S Caron, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1977
Beta-endorphin: stimulation of growth hormone release in vivoA Dupont, L Cusan, M Garon, et al.Biology of Reproduction|February 1, 1993
Ontogenesis of 3 beta-hydroxysteroid dehydrogenase delta 5-delta 4 isomerase in the rat ovary as studied by immunocytochemistry and in situ hybridizationC Juneau, E Dupont, V Luu-The, et al.Bioorganic & Medicinal Chemistry|February 1, 1997
Synthesis and in vitro study of 17 beta-[N-ureylene-N,N'-disubstituted]-4-methyl-4-aza-5 alpha-androstan-3-ones as selective inhibitors of type I 5 alpha-reductaseM Lourdusamy, J Côté, S Laplante, et al.Reviews in Urology|September 21, 2006
Prostate cancer: risk assessment and diagnostic approachesL G Gomella, F Labrie, E J Gamito, et al.European Urology|January 1, 1993
Intracrinology: the basis for the rational design of endocrine therapy at all stages of prostate cancerF Labrie, A Dupont, J Simard, et al.Pageof 59